Concomitant oral ingestion of germanium-132 and curcumin increased mortality rate by aggravating hepatic dysfunction in Long-Evans Cinnamon rats

Journal of Health Science

Volumn 52, Issue 6, 2006, Pages 684-693

  Sunagawa, Masanori ^a   Shingaki, Yasunari ^a   Oonishi, Akira ^b   Nakamura, Mariko ^a   Kosugi, Tadayoshi ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

^b Serotec Laboratory   (Japan)

Author keywords

Curcumin; Germanium 132; Hepatic cancer; Hepatitis; Long Evans Cinnamon rats

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CURCUMIN; GERMANIUM DERIVATIVE; LACTATE DEHYDROGENASE;

AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CINNAMON; CONTROLLED STUDY; FOOD INTAKE; HISTOPATHOLOGY; LIVER DYSFUNCTION; LIVER INJURY; MORTALITY; NONHUMAN; RAT;

CINNAMOMUM VERUM; ZEA MAYS;

EID: 33845448191     PISSN: 13449702     EISSN: 13475207     Source Type: Journal    
DOI: 10.1248/jhs.52.684     Document Type: Article

References (42)

1. Yoshiike, N. and Lwin, H. (2005) Epidemiological aspects of obesity and NASH/NAFLD in Japan. Hepatol. Res., 33, 77-82.
2. Hamaguchi, M., Kojima, T., Takeda, N., Nakagawa, T., Taniguchi, H., Fujii, K., Omatsu, T., Nakajima, T., Sarui, H., Shimazaki, M., Kato, T., Okuda, J. and Ida, K. (2005) The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann. Intern. Med., 143, 722-728.
3. Jiang, M. C., Yang-Yen, H. F., Yen, J. J. and Lin, J. K. (1996) Curcumin induces apoptosis in immortalized NIH 3T3 and malignant cancer cell lines. Nutr. Cancer, 26, 111-120.
4. Kang, H. C., Nan, J. X., Park, P. H., Kim, J. Y., Lee, S. H., Woo, S. W., Zhao, Y. Z., Park, E. J. and Sohn, D. H. (2002) Curcumin inhibits collagen synthesis and hepatic stellate cell activation in-vivo and invitro. J. Pharm. Pharmacol., 54, 119-126.
5. Shukla, Y. and Arora, A. (2003) Suppression of altered hepatic foci development by curcumin in wistar rats. Nutr. Cancer, 45, 53-59.
6. Chuang, S. E., Cheng, A. L., Lin, J. K. and Kuo, M. L. (2000) Inhibition by curcumin of diethylnitrosamine-induced hepatic hyperplasia, inflammation, cellular gene products and cell-cyclerelated proteins in rats. Food Chem. Toxicol., 38, 991-995.
7. Aso, H., Suzuki, F., Ebina, T. and Ishida, N. (1989) Antiviral activity of carboxyethylgermanium sesquioxide (Ge-132) in mice infected with influenza virus. J. Biol. Response Mod., 8, 180-189.
8. Brutkiewicz, R. R. and Suzuki, F. (1987) Biological activities and antitumor mechanism of an immunopotentiating organogermanium compound, Ge-132 (review). In Vivo, 1, 189-203.
9. Kumano, N., Ishikawa, T., Koinumaru, S., Kikumoto, T., Suzuki, S., Nakai, Y. and Konno, K. (1985) Antitumor effect of the organogermanium compound Ge-132 on the Lewis lung carcinoma (3LL) in C57BL/6 (B6) mice. Tohoku J. Exp. Med., 146, 97-104.
10. Suzuki, F., Brutkiewicz, R. R. and Pollard, R. B. (1986) Cooperation of lymphokine(s) and macrophages in expression of antitumor activity of carboxyethylgermanium sesquioxide (Ge-132). Anticancer Res., 6, 177-182.
11. Goodman, S. (1988) Therapeutic effects of organic germanium. Med. Hypotheses, 26, 207-215.
12. Tao, S. H. and Bolger, P. M. (1997) Hazard assessment of germanium supplements. Regul. Toxicol. Pharmacol., 25, 211-219.
13. Woo, J. H., Kim, Y. H., Choi, Y. J., Kim, D. G., Lee, K. S., Bae, J. H., Min do, S., Chang, J. S., Jeong, Y. J., Lee, Y. H., Park, J. W. and Kwon, T. K. (2003) Molecular mechanisms of curcumin-induced cytotoxicity: induction of apoptosis through generation of reactive oxygen species, down-regulation of Bcl-XL and IAP, the release of cytochrome c and inhibition of Akt. Carcinogenesis, 24, 1199-1208.
14. Schauss, A. G. (1991) Nephrotoxicity and neurotoxicity in humans from organogermanium compounds and germanium dioxide. Biol. Trace Elem. Res., 29, 267-280.
15. Kamijo, M., Yagihashi, S., Kida, K., Narita, S. and Nakata, F. (1991) An autopsy case of chronic germanium intoxication presenting peripheral neuropathy, spinal ataxia, and chronic renal failure. Rinsho Shinkeigaku, 31, 191-196.
16. Hess, B., Raisin, J., Zimmermann, A., Horber, F., Bajo, S., Wyttenbach, A. and Jaeger, P. (1993) Tubulointerstitial nephropathy persisting 20 months after discontinuation of chronic intake of germanium lactate citrate. Am. J. Kidney Dis., 21, 548-552.
17. Arts, J. H., Til, H. P., Kuper, C. F., de Neve, R. and Swennen, B. (1994) Acute and subacute inhalation toxicity of germanium dioxide in rats. Food Chem. Toxicol., 32, 1037-1046.
18. Suzuki, K. T. (1995) Disordered copper metabolism in LEC rats, an animal model of Wilson disease: roles of metallothionein. Res. Commun. Mol. Pathol. Pharmacol., 89, 221-240.
19. Powell, C. J. (1994) Copper-overload causes cancer? The LEC rat: a model for human hepatitis, liver cancer, and much more. Hum. Exp. Toxicol., 13, 910-912.
20. Takeichi, N. (1991) Hepatocarcinogenesis in the LEC rat with hereditary hepatitis. Princess Takamatsu Symp., 22, 361-370.
21. Takeichi, N., Kobayashi, H., Yoshida, M. C., Sasaki, M., Dempo, K. and Mori, M. (1988) Spontaneous hepatitis in Long-Evans rats. A potential animal model for fulminant hepatitis in man. Acta Pathol. Jpn., 38, 1369-1375.
22. Yoshida, M. C., Masuda, R., Sasaki, M., Takeichi, N., Kobayashi, H., Dempo, K. and Mori, M. (1987) New mutation causing hereditary hepatitis in the laboratory rat. J. Hered, 78, 361-365.
23. Suzuki, K. T. and Ogura, Y. (2000) Biological regulation of copper and selective removal of copper: therapy for Wilson disease and its molecular mecha nism. Yakugaku Zasshi, 120, 899-908.
24. Cuthbert, J. A. (1995) Wilson's disease: a new gene and an animal model for an old disease. J. Investig Med., 43, 323-336.
25. Sunagawa, M., Shimada, S., Zhang, A., Oonishi, A., Nakamura, M. and Kosugi, T. (2004) Plasma insulin concentration was increased by long-term ingestion of guava juice in spontaneous non-insulin-dependent diabetes mellitus (NIDDM) rats. J. Health Sci., 50, 674-678.
26. Knodell, R. G., Ishak, K. G., Black, W. C., Chen, T. S., Craig, R., Kaplowitz, N., Kiernan, T. W. and Wollman, J. (1981) Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology, 1, 431-435.
27. Sakurai, H., Kamada, H., Fukudome, A., Kito, M., Takeshima, S., Kimura, M., Otaki, N., Nakajima, K., Kawano, K. and Hagino, T. (1992) Copper-metallothionein induction in the liver of LEC rats. Biochem. Biophys. Res. Commun., 185, 548-552.
28. Sugawara, N. and Sugawara, C. (1994) A copper deficient diet prevents hepatic copper accumulation and dysfunction in Long-Evans Cinnamon (LEC) rats with an abnormal copper metabolism and hereditary hepatitis. Arch. Toxicol., 69, 137-140.
29. Takeuchi, A., Yoshizawa, N., Oshima, S., Kubota, T., Oshikawa, Y., Akashi, Y., Oda, T., Niwa, H., Imazeki, N. and Seno, A. (1992) Nephrotoxicity of germanium compounds: report of a case and review of the literature. Nephron, 60, 436-442.
30. Krapf, R., Schaffner, T. and Iten, P. X. (1992) Abuse of germanium associated with fatal lactic acidosis. Nephron, 62, 351-356.
31. Sanai, T., Oochi, N., Okuda, S., Osato, S., Kiyama, S., Komota, T., Onoyama, K. and Fujishima, M. (1990) Subacute nephrotoxicity of germanium dioxide in the experimental animal. Toxicol. Appl. Pharmacol., 103, 345-353.
32. Sanai, T., Okuda, S., Onoyama, K., Oochi, N., Takaichi, S., Mizuhira, V. and Fujishima, M. (1991) Chronic tubulointerstitial changes induced by germanium dioxide in comparison with carboxyethylgermanium sesquioxide. Kidney Int., 40, 882-890.
33. Yokochi, S., Ishiwata, Y., Hashimoto, H., Ninomiya, F. and Suzuki, T. (1998) Hepatoprotective effect of propagermanium on Corynebacterium parvum and lipopolysaccharide-induced liver injury in mice. Scand J. Immunol., 48, 183-191.
34. Huang, T. S., Kuo, M. L., Lin, J. K. and Hsieh, J. S. (1995) A labile hyperphosphorylated c-Fos protein is induced in mouse fibroblast cells treated with a combination of phorbol ester and anti-tumor promoter curcumin. Cancer Lett., 96, 1-7.
35. Yamamoto, H. (1995) Interrelation of differentiation, proliferation and apoptosis in cancer cells. J. Osaka Dent. Univ., 29, 51-60.
36. Sugawara, N., Sugawara, C., Katakura, M., Takahashi, H. and Mori, M. (1991) Copper metabolism in the LEC rat: involvement of induction of metallothionein and disposition of zinc and iron. Experientia, 47, 1060-1063.
37. Sugawara, N., Sugawara, C., Sato, M., Katakura, M., Takahashi, H. and Mori, M. (1991) Copper metabolism in LEC rats aged 30 and 80 days old: induction of Cu-metallothionein and status of zinc and iron. Res. Commun. Chem. Pathol. Pharmacol., 72, 353-362.
38. Yamada, T., Suzuki, Y., Agui, T. and Matsumoto, K. (1992) Elevation of metallothionein gene expression associated with hepatic copper accumulation in Long-Evans Cinnamon mutant rat. Biochim. Biophys. Acta, 1131, 188-191.
39. Sakurai, H., Nakajima, K., Kamada, H., Satoh, H., Otaki, N., Kimura, M., Kawano, K. and Hagino, T. (1993) Copper-metallothionein distribution in the liver of Long-Evans cinnamon rats: studies on immunohistochemical staining, metal determination, gel filtration and electron spin resonance spectroscopy. Biochem. Biophys. Res. Commun., 192, 893-898.
40. Frank, N., Knauft, J., Amelung, F., Nair, J., Wesch, H. and Bartsch, H. (2003) No prevention of liver and kidney tumors in Long-Evans Cinnamon rats by dietary curcumin, but inhibition at other sites and of metastases. Mutat. Res., 523-524, 127-135.
41. Singh, S. and Aggarwal, B. B. (1995) Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane). J. Biol. Chem., 270, 24995-25000.
42. Medici, V., Sturniolo, G. C., Santon, A., D'Inca, R., Bortolami, M., Cardin, R., Basso, D., Albergoni, V. and Irato, P. (2005) Efficacy of zinc supplementation in preventing acute hepatitis in Long-Evans Cinnamon rats. Liver Int., 25, 888-895.